The principal market for our Common Stock is the New York Stock Exchange. Our stock is also traded on various U.S. regional stock exchanges.
Stock Transfer Agent and Registrar
Computershare Investor Services
P.O. Box 505000
Louisville, KY 40233-5000
Telephone: (800) 733-9393
Outside the U.S., Canada and Puerto Rico: (781) 575-4591
Internet: www.computershare.com/investor
Please contact our Stock Transfer Agent and Registrar, Computershare, with inquiries concerning shareholder accounts of record and stock transfer matters, and for information:
Computershare Investment Program.
Direct purchase of Pfizer stock.
Dividend Reinvestment.
Automatic monthly or bimonthly investments.
To learn more about public policy at Pfizer, visit https://www.pfizer.com/purpose/contributions-partnerships/political-partnerships.
You can find more information about Pfizer online:
Website: www.pfizer.com
Twitter: www.twitter.com/Pfizer
Facebook: www.facebook.com/Pfizer
We may use our website as a means of disclosing material information and for complying with our disclosure obligations under Regulation Fair Disclosure promulgated by the SEC. These disclosures are included on our website in the “Investors” or “News” sections. Accordingly, investors should monitor these portions of our website, in addition to following Pfizer’s press releases, SEC filings, public conference calls and webcasts, as well as Pfizer’s social media channels (Pfizer’s Facebook, YouTube and LinkedIn pages and Twitter accounts (@Pfizer and @Pfizer_News)).
The information contained on our website, our Facebook, YouTube and LinkedIn pages or our Twitter accounts is not incorporated by reference into this 2020 Annual Review.
The 2020 Annual Review may contain references or links to other websites maintained by third parties over whom Pfizer has no control. Such links are provided merely as a convenience. Pfizer makes no warranties or representations of any kind as to the accuracy, currency, or completeness of any information contained in such third-party websites, including any third-party social media or mobile app platform. Inclusion of any third-party link in this 2020 Annual Review does not imply an endorsement or recommendation by Pfizer and a link to this 2020 Annual Review from another website does not imply a relationship between Pfizer and any third party. Your use of any such third-party site or platform is at your own risk and will be governed by such third party's terms and policies (including its privacy policy).
Unless otherwise noted herein, the trademarks, logos and service marks appearing in the Annual Review, whether or not appearing with the trademark symbol, are owned or licensed by Pfizer Inc. or its affiliates.
Bavencio® is a registered trademark of Merck KGaA.
Chairman and CEO Albert Bourla reflects on a year of breakthrough innovation at Pfizer
Science illuminates a path forward for patients across the world
Courage, excellence, equity and joy guide all our endeavors
2020 by the numbers
Read the latest information about Pfizer’s COVID-19 vaccine on Pfizer.com.
Visit Pfizer.com
The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.
Copyright © 2020-2021 Pfizer Inc.
All rights reserved